The US Lymphedema Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)
Scope of the Report
The report titled entitled “The US Lymphedema Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, number of patients and penetration, number of patients diagnosed, patients by causes and demographics, etc. The report also provides the detailed analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by average selling price, etc.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2020-2024, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
The major players dominating the US Lymphedema market are Tactile Systems Technology Inc., Bio Compression System, Lympha Press (Mego Afek) and Essity (BSN Medical). The four companies have been profiled in the report providing detailed analysis of their financial information and business strategies.
Company Coverage
There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
The US Lymphedema market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2024). The market is expected to be driven by various growth enhancing factors such as growing prevalence of breast cancer, increasing obesity, rise in urban population, escalating healthcare expenditure, rising prevalence of arthritis, and surge in the disposable income.
However, the market is not free from challenges that are hindering its growth. Some of the major challenges faced by the market are high cost involved, improvement in cancer treatment, and lack of awareness.
The report titled entitled “The US Lymphedema Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, number of patients and penetration, number of patients diagnosed, patients by causes and demographics, etc. The report also provides the detailed analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by average selling price, etc.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2020-2024, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
The major players dominating the US Lymphedema market are Tactile Systems Technology Inc., Bio Compression System, Lympha Press (Mego Afek) and Essity (BSN Medical). The four companies have been profiled in the report providing detailed analysis of their financial information and business strategies.
Company Coverage
- Tactile Systems Technology Inc
- Bio Compression System
- Lympha Press (Mego Afek)
- Essity (BSN Medical)
There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
The US Lymphedema market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2024). The market is expected to be driven by various growth enhancing factors such as growing prevalence of breast cancer, increasing obesity, rise in urban population, escalating healthcare expenditure, rising prevalence of arthritis, and surge in the disposable income.
However, the market is not free from challenges that are hindering its growth. Some of the major challenges faced by the market are high cost involved, improvement in cancer treatment, and lack of awareness.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Lymphedema: An Overview
2.2 Types of Lymphedema
2.3 Treatment of Lymphedema
3. MARKET ANALYSIS
3.1 The US Lymphedema Market: An Analysis
3.1.1 The US Lymphedema Market by Number of Patients
3.1.2 The US Lymphedema Market by Number of Patients Diagnosed
3.1.3 The US Lymphedema Market by Number of Diagnosed Patients Severity
3.2 The US Lymphedema Market: Patient Analysis
3.2.1 The US Lymphedema Patients by Causes
3.2.2 The US Lymphedema Patients by Demographics
3.3 The US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 The US Pneumatic Compression Device (PCD) Market by Value
3.4 The US Lymphedema Market: New Product Analysis
3.4.1 The US Lymphedema Market New Product: LYT-100
3.4.2 The US Lymphedema Market New Product: Ubenimex
3.4.3 The US Lymphedema Market New Product: Lymfactin
4. IMPACT OF COVID-19
4.1 Impact on Market Players
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Growing Prevalence of Breast Cancer
5.1.2 Increasing Obesity
5.1.3 Rise in Urban Population
5.1.4 Escalating Healthcare Expenditure
5.1.5 Rising Prevalence of Arthritis
5.1.6 Surge in the Disposable Income
5.2 Challenges
5.2.1 High Cost Involved
5.2.2 Improvement in Cancer Treatment
5.2.3 Lack of Awareness
5.3 Market Trends
5.3.1 Advancement in Treatment Options
5.3.2 Growing Popularity of Pneumatic Compression Devices
6.COMPETITIVE LANDSCAPE
6.1 The US PCD Players by Market Share
6.2 The US PCD Market Players Comparison
7. COMPANY PROFILES
7.1 Tactile Systems Technology Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Bio Compression System
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Lympha Press (Mego Afek)
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Essity (BSN Medical)
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
2. INTRODUCTION
2.1 Lymphedema: An Overview
2.2 Types of Lymphedema
2.3 Treatment of Lymphedema
3. MARKET ANALYSIS
3.1 The US Lymphedema Market: An Analysis
3.1.1 The US Lymphedema Market by Number of Patients
3.1.2 The US Lymphedema Market by Number of Patients Diagnosed
3.1.3 The US Lymphedema Market by Number of Diagnosed Patients Severity
3.2 The US Lymphedema Market: Patient Analysis
3.2.1 The US Lymphedema Patients by Causes
3.2.2 The US Lymphedema Patients by Demographics
3.3 The US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 The US Pneumatic Compression Device (PCD) Market by Value
3.4 The US Lymphedema Market: New Product Analysis
3.4.1 The US Lymphedema Market New Product: LYT-100
3.4.2 The US Lymphedema Market New Product: Ubenimex
3.4.3 The US Lymphedema Market New Product: Lymfactin
4. IMPACT OF COVID-19
4.1 Impact on Market Players
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Growing Prevalence of Breast Cancer
5.1.2 Increasing Obesity
5.1.3 Rise in Urban Population
5.1.4 Escalating Healthcare Expenditure
5.1.5 Rising Prevalence of Arthritis
5.1.6 Surge in the Disposable Income
5.2 Challenges
5.2.1 High Cost Involved
5.2.2 Improvement in Cancer Treatment
5.2.3 Lack of Awareness
5.3 Market Trends
5.3.1 Advancement in Treatment Options
5.3.2 Growing Popularity of Pneumatic Compression Devices
6.COMPETITIVE LANDSCAPE
6.1 The US PCD Players by Market Share
6.2 The US PCD Market Players Comparison
7. COMPANY PROFILES
7.1 Tactile Systems Technology Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Bio Compression System
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Lympha Press (Mego Afek)
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Essity (BSN Medical)
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Type of Lymphedema
Figure 2: Treatment of Lymphedema
Figure 3: The US Lymphedema Market by Number of Patients; 2017-2019 (Million)
Figure 4: The US Lymphedema Market by Number of Patients and Penetration; 2020-2024 (Million)
Figure 5: The US Lymphedema Market by Number of Patients Diagnosed; 2017-2019 (Million, Percentage, %)
Figure 6: The US Lymphedema Market by Number of Patients Diagnosed; 2020-2024 (Million, Percentage, %)
Figure 7: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2017-2019 (Thousand)
Figure 8: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2020-2024 (Thousand)
Figure 9: The US Lymphedema Patients by Causes
Figure 10: The US Lymphedema Patients by Gender
Figure 11: The US Lymphedema Patients by Age Group
Figure 12: The US Pneumatic Compression Device (PCD) Market by Value; 2019-2024 (US$ Million)
Figure 13: Lymfactin Phase Study
Figure 14: The US Estimated Number of New Breast Cancer Cases; 2015-2019 (Thousand)
Figure 15: The US Obesity Rates; 2015-2030 (Percentage, %)
Figure 16: The US Urban Population; 2014-2018 (Million)
Figure 17: The US Healthcare Expenditure; 2012-2024 (US$ Trillion)
Figure 18: The US Arthritis Population; 2010-2040 (Million)
Figure 19: The US Per Capita Disposable Personal Income; 2012-2018 (US$ Trillion)
Figure 20: The US PCD Players by Market Share; 2016-2021 (Percentage, %)
Figure 21: Tactile Systems Technology Inc. Revenue; 2015-2019 (US$ Million)
Figure 22: Tactile Systems Technology Inc. Revenue by Segments; 2019 (Percentage, %)
Figure 23: Essity Net Sales; 2014-2018 (US$ Billion)
Figure 24: Essity Net Sales by Segments; 2018 (Percentage, %)
Figure 25: Essity Net Sales by Region; 2018 (Percentage, %)
Table 1: Lymphedema Classification Scale
Table 2: Ubenimex Milestones – Lymphedema
Table 3: The US PCD Market Players Compariso
Figure 1: Type of Lymphedema
Figure 2: Treatment of Lymphedema
Figure 3: The US Lymphedema Market by Number of Patients; 2017-2019 (Million)
Figure 4: The US Lymphedema Market by Number of Patients and Penetration; 2020-2024 (Million)
Figure 5: The US Lymphedema Market by Number of Patients Diagnosed; 2017-2019 (Million, Percentage, %)
Figure 6: The US Lymphedema Market by Number of Patients Diagnosed; 2020-2024 (Million, Percentage, %)
Figure 7: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2017-2019 (Thousand)
Figure 8: The US Lymphedema Market by Number of Diagnosed Patients Severity; 2020-2024 (Thousand)
Figure 9: The US Lymphedema Patients by Causes
Figure 10: The US Lymphedema Patients by Gender
Figure 11: The US Lymphedema Patients by Age Group
Figure 12: The US Pneumatic Compression Device (PCD) Market by Value; 2019-2024 (US$ Million)
Figure 13: Lymfactin Phase Study
Figure 14: The US Estimated Number of New Breast Cancer Cases; 2015-2019 (Thousand)
Figure 15: The US Obesity Rates; 2015-2030 (Percentage, %)
Figure 16: The US Urban Population; 2014-2018 (Million)
Figure 17: The US Healthcare Expenditure; 2012-2024 (US$ Trillion)
Figure 18: The US Arthritis Population; 2010-2040 (Million)
Figure 19: The US Per Capita Disposable Personal Income; 2012-2018 (US$ Trillion)
Figure 20: The US PCD Players by Market Share; 2016-2021 (Percentage, %)
Figure 21: Tactile Systems Technology Inc. Revenue; 2015-2019 (US$ Million)
Figure 22: Tactile Systems Technology Inc. Revenue by Segments; 2019 (Percentage, %)
Figure 23: Essity Net Sales; 2014-2018 (US$ Billion)
Figure 24: Essity Net Sales by Segments; 2018 (Percentage, %)
Figure 25: Essity Net Sales by Region; 2018 (Percentage, %)
Table 1: Lymphedema Classification Scale
Table 2: Ubenimex Milestones – Lymphedema
Table 3: The US PCD Market Players Compariso
